1. Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence – a systematic review and meta-analysis

   • Susanna M. Wallerstedt
   • Astrid Nilsson Ek
   • Barbro Linderholm

   Review Open access 05 June 2020 Pages: 1199 - 1211

   

2. Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib

   • Christel C. L. M. Boons
   • Lonneke Timmers
   • Jacqueline G. Hugtenburg

   Clinical Trial Open access 02 June 2020 Pages: 1213 - 1226

   

3. Establishment of reference intervals of biochemical analytes for healthy Chinese volunteers during the screening process in clinical pharmacology trials

   • Ping Zhong
   • Huanwen Chen
   • Jianfeng Liu

   Clinical Trial 03 June 2020 Pages: 1227 - 1235

4. First-in-human dose: current status review for better future perspectives

   • Archana Mishra
   • Sudhir Chandra Sarangi
   • Kh Reeta

   Clinical Trial 03 June 2020 Pages: 1237 - 1243

   

5. A novel mechanism of ACE inhibition–associated enhanced platelet reactivity: disproof of the ARB-MI paradox?

   • Carolin Helten
   • Philipp Mourikis
   • Amin Polzin

   Pharmacodynamics 05 June 2020 Pages: 1245 - 1251

   

6. Effect of a rabeprazole half-dose twice daily on acid inhibition in patients with different CYP2C19 alleles

   • Masaki Murata
   • Mitsushige Sugimoto

   Pharmacodynamics 02 June 2020 Pages: 1253 - 1261

   

7. Age-dependent association of CYP2C19 polymorphisms with clinical outcome of clopidogrel therapy in minor stroke patients with large-artery atherosclerosis

   • Dapeng Wang
   • Lingjie Li
   • Qi Fang

   Pharmacogenetics 05 June 2020 Pages: 1263 - 1271

8. Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma

   • Greet Van De Sijpe
   • Benoit Beuselinck
   • Isabel Spriet

   Pharmacokinetics and Disposition 30 May 2020 Pages: 1273 - 1280

   

9. External evaluation of population pharmacokinetic models for continuous administration of meropenem in critically ill adult patients

   • YL. Wang
   • R. Guilhaumou
   • Amélie Marsot

   Pharmacokinetics and Disposition 04 June 2020 Pages: 1281 - 1289

   

10. Aggregation and analysis of indication-symptom relationships for drugs approved in the USA

    • Ananth Punyala
    • Rachana Lankapalli
    • Rebecca Racz

    Pharmacoepidemiology and Prescription Open access 03 June 2020 Pages: 1291 - 1299

    

11. Real-world data on new users of atypical antipsychotics: characterisation, prescription patterns, healthcare costs and early cardio-metabolic occurrences from a large Italian database

    • Carlo Piccinni
    • Letizia Dondi
    • Nello Martini

    Pharmacoepidemiology and Prescription 28 May 2020 Pages: 1301 - 1310

    

12. Borrowing external information to improve Bayesian confidence propagation neural network

    • Keisuke Tada
    • Kazushi Maruo
    • Masahiko Gosho

    Pharmacoepidemiology and Prescription 01 June 2020 Pages: 1311 - 1319

    

13. Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study

    • Jean-Louis Montastruc
    • Vanessa Rousseau
    • François Montastruc

    Pharmacoepidemiology and Prescription 01 June 2020 Pages: 1321 - 1327

    

14. Use of selective serotonin reuptake inhibitors, other antidepressant medication, and risk of cataract: a case-control study based on Swiss claims data

    • Claudia Becker
    • Matthias Schwenkglenks
    • Christoph R. Meier

    Pharmacoepidemiology and Prescription 06 June 2020 Pages: 1329 - 1335

15. Pharmacokinetics of imipenem in both plasma and peritoneal draining liquid in elder patients with perforated upper gastrointestinal tract

    • Lingti Kong
    • Jian Xu
    • Lei Li

    Letter to the Editor 30 May 2020 Pages: 1337 - 1339

    

16. Leflunomide-induced recurrent-transient ischaemic attacks in a patient with rheumatoid arthritis: first case report

    • Cristian Eduardo Navarro
    • Pilar Enríquez-Ruano
    • Maira Nataly Enríquez-Ruano

    Letter to the Editor 28 May 2020 Pages: 1341 - 1342

    

17. No association between hydrochlorothiazide use and uveal melanoma

    • Anton Pottegård
    • Sidsel Arnspang Pedersen
    • Kasper Bruun Kristensen

    Letter to the Editor 03 June 2020 Pages: 1343 - 1344